Company Profile:

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. Integra LifeSciences Holdings Corporation offers its products directly through various sales forces and other distribution channels in the United States, Europe, and internationally. The company was founded in 1989 and is headquartered in Plainsboro, New Jersey.

Recent News:

The company will release third quarter 2018 financial results on Wednesday, October 31, 2018, prior to market open.

For the second quarter ending June 30, 2018, the company reported revenue of $366.2 million, an increase of 29.8% compared to the second quarter of 2017. GAAP earnings per share was $0.14, flat compared to the second quarter of 2017.

Fundamental Analysis:

Ninestocks analyzes several different financial aspects: Growth, Profitability, solvency and efficiency.

Growth – Measures the growth of both the company’s income statement and cash flow.

@@@@@

Profitability – Measures the historical price movement of the stock.

@@@@@

Solvency – Measures the solvency of the company based on several ratios.

@@@@@

Efficiency – Measures the strength and historic growth of a company’s return on invested capital.

@@@@@

Conclusion:

IART’s strengths can be seen in its strong growth and better profitability compared with its peers. Technical indicators signal the bullish signs, as there is a bullish crossover in Stochastic oscillator, RSI is strong in the bullish zone and MACD is trying to cross back up. We rate Integra LifeSciences Holdings Corporation (IART) a STRONG BUY.